Zosano Pharma Corporation
ZSAN
ZSAN was delisted on the 10th of June, 2022.
13 hedge funds and large institutions have $13.4M invested in Zosano Pharma Corporation in 2015 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 5 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
13% less funds holding
Funds holding: 15 → 13 (-2)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
47% less capital invested
Capital invested by funds: $25.3M → $13.4M (-$11.8M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.21M |
| 2 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
+$56.5K |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$11.7K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.95K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Visium Asset Management
New York
|
-$1.64M |
| 2 |
BC
Broadfin Capital
New York
|
-$1.47M |
| 3 |
PAI
ProQuest Associates IV
Naples,
Florida
|
-$910K |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$396K |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$292K |
ZSAN Hedge Fund Activity: Q4 2015 in Review
13 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Zosano Pharma Corporation (ZSAN) for Q4 2015, worth a combined $13.4M — down 47% from $25.3M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of ZSAN and 3 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 4 added.
The largest buyer was Fidelity Investments, adding an estimated $2.21M. The largest seller was Visium Asset Management, exiting entirely with an estimated $1.64M sold.
- 13 institutional investors held Zosano Pharma Corporation (ZSAN) as of Q4 2015, down from 15 in Q3 2015.
- Funds reported $13.4M of Zosano Pharma Corporation stock for Q4 2015, down 47% quarter-over-quarter.
- 3 funds opened new Zosano Pharma Corporation positions in Q4 2015 and 5 closed out, a net change of -2 holders.
- The largest Zosano Pharma Corporation buyer in Q4 2015 was Fidelity Investments, an estimated $2.21M added.
- The largest Zosano Pharma Corporation seller in Q4 2015 was Visium Asset Management, an estimated $1.64M sold.
Based on aggregated 13F filings for Q4 2015.